Welcome to the Oncomine Blog
Evaluating NGS technologies for in-house comprehensive genomic profiling
11/13/2024 |
Research
In everyday practice, it is common for pathology labs to evaluate >50% cytological specimens across solid tumors especially in lung and pancreatic...
-
Q2 Solutions Eyes Genexus System as its Game-Changing Solution for Global Clinical Trial Services
When it comes to supporting clinical trials, having a global footprint is simply not enough for cont... -
Shifting the Paradigm: Broader Patient Access to Personalized Oncology Treatments Hinges on In-House Comprehensive Genomic Testing
We are living in an unprecedented time in the collective fight against cancer, where recent developm... -
The Importance of Detecting the Most Fusions Across the Most Patients
In recent years, we’ve seen an increasing number of new therapies emerge that target gene fusions in...